hydroxyurea

The medicinal product is used in adults for the treatment of blood disorders: chronic myeloid leukaemia, essential thrombocythemia, and polycythemia vera.

Form: capsules, hard

ATC: L01XX05

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.

The medicinal product is used in the treatment of chronic myeloproliferative disorders (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia, and myelofibrosis) and in sickle cell anemia, to prevent the recurrence of painful crises.

Form: capsules

ATC: L01XX05

Manufacturer: PLIVA Kraków Pharmaceutical Plants S.A. Teva Operations Polska Sp. z o.o.

The medicine is used in the treatment of chronic myeloid leukemia (in the chronic or accelerated phase) and in the treatment of essential thrombocythemia or polycythemia vera, if there is a high risk of thromboembolic complications.

Form: capsules, hard

ATC: L01XX05

Manufacturer: medac Gesellschaft fur klinische Specialpraparate GmbH